Nebula Research & Development’s Oscar Health OSCR Stock Holding History

Nebula Research & Development’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-95,463	Closed	-$1.25M	–	1103
2025 Q1	$1.25M	Buy	95,463 +60,449	+173%	+$897K	0.12%	297
2024 Q4	$471K	Sell	35,014 -85,981	-71%	-$1.38M	0.06%	579
2024 Q3	$2.57M	Buy	120,995 +5,489	+5%	+$98.9K	0.31%	58
2024 Q2	$1.83M	Buy	115,506 +31,620	+38%	+$581K	0.3%	73
2024 Q1	$1.25M	Buy	83,886 +73,009	+671%	+$1,000K	0.27%	92
2023 Q4	$99.5K	Sell	10,877 -19,903	-65%	-$137K	0.03%	610
2023 Q3	$171K	Sell	30,780 -3,824	-11%	-$26.8K	0.09%	419
2023 Q2	$279K	Buy	+34,604	New	+$255K	0.21%	224

Other funds holding OSCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nebula Research & Development's OSCR Position: Q2 2025 in Review

Nebula Research & Development sold out of Oscar Health (OSCR) in Q2 2025, closing a stake of 95,463 shares — an estimated $1.25M sold.

Nebula Research & Development first reported a position in OSCR in Q2 2023 and held it in 8 quarters. The position peaked at $2.57M in Q3 2024. 332 funds tracked by Wall St. Rank hold OSCR as of Q2 2025.

Nebula Research & Development reported no remaining Oscar Health position as of Q2 2025 after selling out during the quarter.
Nebula Research & Development sold 95,463 Oscar Health shares in Q2 2025, an estimated $1.25M.
Nebula Research & Development first reported a position in Oscar Health in Q2 2023 and held it in 8 quarters.
Nebula Research & Development's Oscar Health position peaked at $2.57M in Q3 2024.
332 funds tracked by Wall St. Rank held Oscar Health as of Q2 2025.

Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.